Correlation Between Gilead Sciences and ProMIS Neurosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and ProMIS Neurosciences, you can compare the effects of market volatilities on Gilead Sciences and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and ProMIS Neurosciences.

Diversification Opportunities for Gilead Sciences and ProMIS Neurosciences

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Gilead and ProMIS is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and ProMIS Neurosciences go up and down completely randomly.

Pair Corralation between Gilead Sciences and ProMIS Neurosciences

Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.31 times more return on investment than ProMIS Neurosciences. However, Gilead Sciences is 3.26 times less risky than ProMIS Neurosciences. It trades about 0.07 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about 0.0 per unit of risk. If you would invest  8,826  in Gilead Sciences on October 25, 2024 and sell it today you would earn a total of  466.00  from holding Gilead Sciences or generate 5.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Gilead Sciences  vs.  ProMIS Neurosciences

 Performance 
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound essential indicators, Gilead Sciences is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
ProMIS Neurosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ProMIS Neurosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy primary indicators, ProMIS Neurosciences is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Gilead Sciences and ProMIS Neurosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gilead Sciences and ProMIS Neurosciences

The main advantage of trading using opposite Gilead Sciences and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.
The idea behind Gilead Sciences and ProMIS Neurosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges